After the exclusion of concurrent molecular alterations, only two nodules with TP53 alterations were divided into the high-risk group, one (TP53P82Rfs∗66) of which was follicular thyroid carcinoma (FTC) with partial differentiation. Here, TP53 is linked to thyroid cancer, nonmedullary, 2.